Qube Research & Technologies (QRT)
CAH icon

Qube Research & Technologies (QRT)’s Cardinal Health CAH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570K Sell
2,400
-2,000
-45% -$416K ﹤0.01% 2614
2026
Q1 		$930K Sell
4,400
-1,100
-20% -$237K ﹤0.01% 2526
2025
Q4 		$1.13M Buy
+5,500
New +$1.04M ﹤0.01% 2502
2023
Q4 		– Sell
-2,900
Closed -$252K – 4365
2023
Q3 		$252K Buy
+2,900
New +$262K ﹤0.01% 2314

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Qube Research & Technologies (QRT)'s CAH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cardinal Health (CAH) stake by 89% in Q2 2026, selling an estimated $188M and leaving 108,557 shares worth $25.8M. The position accounts for 0.02% of the portfolio, ranked #798.

Qube Research & Technologies (QRT) first reported a position in CAH in Q2 2018 and has held it in 21 quarters since. The position peaked at $239M in Q2 2025. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 108,557 shares of Cardinal Health worth $25.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 903,752 Cardinal Health shares in Q2 2026, an estimated $188M.
  • Cardinal Health made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #798 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cardinal Health in Q2 2018 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s Cardinal Health position peaked at $239M in Q2 2025.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.